The post - operative infection and rejection rates in the patients underwent renal transplantation might be reduced evidently when FK506 and MME were used to substitute CsA and Aza in the immunosuppressive scheme for the post-operative management.

• 用FK506+MMF代替CsA与Aza可以显著减少肾移植术后的感染率,降低排斥反应,并提高移植肾成活率。